Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.33 USD | -2.92% | -41.01% | -65.40% |
04-24 | Motion for Asset Sale Approved for Eiger BioPharmaceuticals, Inc. | CI |
04-19 | Selection of Successful Bidder Filed by Eiger BioPharmaceuticals, Inc. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-65.40% | 3.55M | |
+22.66% | 42.68B | |
-3.32% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+8.10% | 24.94B | |
-20.18% | 18.96B | |
+29.39% | 12.3B | |
-2.87% | 11.95B | |
-1.63% | 11.55B |
- Stock Market
- Equities
- EIGR Stock
- News Eiger BioPharmaceuticals, Inc.
- Eiger BioPharmaceuticals : Wedbush Suspended Coverage on Eiger BioPharmaceuticals